Perpetua Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	14.56	6.94	9.94	10.11	8.82
Other Revenue	0	-	-	-	-
Revenue	14.56	6.94	9.94	10.11	8.82
Revenue Growth (YoY)	109.84%	-30.16%	-1.76%	14.73%	363.72%
Cost of Revenue	6.96	3.8	4.09	3.47	2.89
Gross Profit	7.6	3.14	5.85	6.65	5.93
Selling, General & Admin	14.89	10.94	23.78	25.56	19.37
Other Operating Expenses	-11.83	-5.66	0.38	-0.19	-0.14
Operating Expenses	5.56	5.6	24.34	25.76	19.61
Operating Income	2.04	-2.46	-18.49	-19.11	-13.68
Interest Expense	-0.7	-0.08	-0.07	-0.13	-0.15
Interest & Investment Income	0.08	0.29	0.29	0.07	0.12
Earnings From Equity Investments	-0.23	-	-	-	-
Other Non Operating Income (Expenses)	-	-	-	-0	-
EBT Excluding Unusual Items	1.19	-2.24	-18.28	-19.16	-13.71
Gain (Loss) on Sale of Assets	-	0.04	-	-	-
Pretax Income	1.19	-2.2	-18.28	-19.16	-13.71
Income Tax Expense	-0.02	0.18	-	-	-
Earnings From Continuing Operations	1.22	-2.38	-18.28	-19.16	-13.71
Minority Interest in Earnings	1.24	-0.09	-	-	-
Net Income	2.45	-2.47	-18.28	-19.16	-13.71
Net Income to Common	2.45	-2.47	-18.28	-19.16	-13.71
Shares Outstanding (Basic)	5	4	2	1	1
Shares Outstanding (Diluted)	5	4	2	1	1
Shares Change (YoY)	9.65%	145.32%	153.20%	20.61%	20.91%
EPS (Basic)	0.53	-0.58	-10.56	-28.03	-24.18
EPS (Diluted)	0.53	-0.58	-10.56	-28.03	-24.18
Free Cash Flow	-6.53	-7.03	-16.41	-19.65	-15.84
Free Cash Flow Per Share	-1.40	-1.66	-9.48	-28.74	-27.94
Gross Margin	52.21%	45.27%	58.85%	65.72%	67.26%
Operating Margin	14.04%	-35.39%	-186.11%	-188.94%	-155.22%
Profit Margin	16.84%	-35.64%	-183.94%	-189.48%	-155.54%
Free Cash Flow Margin	-44.87%	-101.27%	-165.16%	-194.31%	-179.68%
EBITDA	4.55	-2.13	-18.31	-18.72	-13.3
EBITDA Margin	31.21%	-30.73%	-184.31%	-185.10%	-150.87%
D&A For EBITDA	2.5	0.32	0.18	0.39	0.38
EBIT	2.04	-2.46	-18.49	-19.11	-13.68
EBIT Margin	14.04%	-35.39%	-186.11%	-188.94%	-155.22%
Revenue as Reported	26.51	14.15	9.98	10.42	9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.